Puma Biotechnology, Inc., a biopharmaceutical company, announced that on July 23, 2019 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 52,501 shares of Puma common stock to seven new non-executive employees.
August 6, 2019
· 2 min read